ADVFN - Advanced Financial Network.
HOME» NYSE » M » MDT Stock Price » MDT Stock News

Medtronic Share News

 Medtronic, Inc. Stock Price
MDT Stock Price
 Medtronic, Inc. Stock Chart
MDT Stock Chart
 Medtronic, Inc. Stock News
MDT Stock News
 Medtronic, Inc. Company Information
MDT Company Information
 Medtronic, Inc. Stock Trades
MDT Stock Trades

Hospitals Surge, Insurers Slide as Health-Care Law is Upheld

By Jon Kamp Thursday's historic Supreme Court ruling upholding the U.S. health-care overhaul law sent stocks throughout the health-care sector in different directions by maintaining the promise of more people seeking services, but also new costs and other big changes. By upholding the politically contentious law, the high court keeps alive this complex mix of opportunities and pressure points, at least through November's elections. The law aims to extend coverage to tens of millions of Americans through state-based exchanges and a broader Medicaid program while imposing various cuts and taxes on health companies. Hospital operators broadly posted big gains because the upheld law promises coverage for millions of Americans who might otherwise seek care and stick hospitals with unpaid bills. Big managed-care firms--which are slated to get new customers from the law but also face earnings-compressing coverage requirements--traded lower. Overall, the NYSE Healthcare Index recently traded down about 1%, matching broader-market declines amid widely divergent moves throughout the health-care sector. Hospitals helped lead the charge higher, with HCA Holdings Inc. (HCA), the biggest investor-owned hospital company, jumping 7.8% in recent trading. Community Health Systems Inc. (CYH) rose 10.9% and Tenet Healthcare Corp. (THC) rose 7.6%. Hospitals are the "net winners" here, having won a best-case-scenario outcome, according to Goldman Sachs. Among big health insurers, UnitedHealth Group Inc. (UNH) fell 3.3%, Aetna Inc. (AET) sank 4.5% and WellPoint Inc. (WLP) declined 6.3%. Thursday's ruling keeps in place a law poised to add customers but also pressure earnings through new requirements, such as taking on people regardless of their health history and not charging more for pre-existing conditions. Predictions ahead of the ruling were all over the map, although expectations the law would be totally upheld declined significantly after oral arguments before the court in March. "Modest declines in the shares of commercial insurers suggest at least some investors expected the law to be struck down," Wells Fargo analyst Peter Costa said. According to Goldman Sachs analysis, earnings for big insurers would have been highest over the next four years if the law was struck down. Thursday's ruling was more of a middle-ground outcome for insurers amid investor hopes for more. Meantime, shares of Medicaid-focused insurers jumped on expectations that the health plan for the poor will expand to add millions more people, with WellCare Health Plans Inc. (WCG) up 8.9%, Amerigroup Corp. (AGP) up 4.3% and Molina Healthcare Inc. (MOH) up 4.1%. The high court said the federal government can't put sanctions on states' existing Medicaid funding if the states decline to go along with the expansion, but can withhold new funds if the states don't comply with the requirements. Shares were down in the medical-device sector, where the law means companies are set to start paying an excise tax on domestic sales next year. Medtronic Inc. (MDT), which has estimated a $120 million to $150 million annual impact, slid 1.2%. Spinal-device maker NuVasive Inc. (NUVA) declined 2.1%. Write to Jon Kamp at jon.kamp@dowjones.com

Stock News for Medtronic (MDT)
DateTimeHeadline
12/07/201420:25:13Deals Fuel Bond Boom
12/01/201419:54:39Medtronic's $17 Billion Bond Sale Is Year's Largest -- Update
12/01/201415:23:29Medtronic Selling Bonds for Covidien Acquisition -- Update
12/01/201410:49:16Medtronic Selling Bonds for Covidien Acquisition
11/28/201407:44:24EU Approves Medtronic's $43 Billion Merger With Covidien
11/26/201418:35:25Medtronic Acquisition of Covidien Receives U.S. FTC Clearance
11/18/201413:41:57Medtronic Sales Rise, Backs Covidien Deal -- 2nd Update
11/18/201413:34:48Correction to Medtronic Earnings Story
11/18/201410:41:22Medtronic Sales Drop in Core Pacemaker Business -- Update
11/18/201408:41:24Medtronic Revenue Grows 5%, Backs Commitment to Covidien Deal
11/17/201412:59:18Medtronic Profit, Sales Seen Rising in 2Q -- Earnings Preview
11/17/201406:28:22MARKET SNAPSHOT: Retailers Close Out Earnings Season
11/05/201409:45:59U.S. Hot Stocks: Hot Stocks to Watch
10/15/201417:05:13MARKET SNAPSHOT: U.S. Stocks Cut Losses In Harrowing, Volatile...
10/15/201414:50:29MARKET SNAPSHOT: U.S. Stocks Plummet As Selling Intensifies
09/15/201405:43:10Danaher Buys Nobel Biocare for About $2.1 Billion
09/15/201403:24:48Danaher Buys Nobel Biocare in $2.1 Billion Cash Deal
08/26/201407:20:42Medtronic Buys Brain-Stimulation Firm
08/26/201406:59:04Medtronic Buys Brain-Stimulation Firm for $200 Million
08/21/201416:13:51Inversions Push Falls to Treasury's Mark J. Mazur

Medtronic and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad